iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Sundram Fasteners announced that the Board of Directors of the Company at its meeting held on 10 February 2022 has recommended a Interim dividend of Rs645 per share ie645Percentage subject to the approval of the shareholders

image

Somany Home Innovation announced that the Board of Directors of the Company at its meeting held on 10 February 2022 has recommended a Interim dividend of Rs050 per share ie25Percentage subject to the approval of the shareholders

image

Kesoram Industries announced that ICRA has assigned a long-term rating of [ICRA]BBB- pronounced ICRA triple B minus Rating to Kesoram Industries The Outlook on the long-term rating is Stable

image

Innovation Software Exports will hold a meeting of the Board of Directors of the Company on 14 February 2022

image

Foseco India announced that the Board of Directors of the Company at its meeting held on 10 February 2022 has recommended a Final dividend of Rs25 per share ie250Percentage subject to the approval of the shareholders

image

The Board of TV Today Network at its meeting held on 11 February 2022 has approved the re-designation of Dinesh Bhatia the Current Group Head – Strategy as Group Chief Executive Officer KMP of the Company subject to requisite approvals

image

ABB India announced that the Board of Directors of the Company at its meeting held on 10 February 2022 has recommended a Final dividend of Rs520 per share ie260Percentage subject to the approval of the shareholders

image

Max Healthcare Institute today announced the deal to acquire Eqova Healthcare Eqova a company with long term exclusive rights to aid development of and provide medical services to a 400 bed hospital to be built on 21 acres of land parcel in Patparganj Delhi owned by Nirogi Charitable and Medical Research Trust The hospital will be located on NH 24 expressway and falls on the […]

image

Alkem Laboratories has signed a license agreement with Harvard Universitys Office of Technology Development OTD enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy foot ulcers peripheral arterial disease PAD and other injuries caused by vascular disease The license grants Alkem commercialization rights in the United States and India

image

JSW Energy announced that CARE Ratings CARE has withdrawn their rating assigned to the Non-Convertible Debentures of Rs 300 crore as the same has been fully paid by the Company

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.